홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Dasabuvir

HCID 56640146
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
1132935-63-7
표준 SMILES
COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C
InChIKey
NBRBXGKOEOGLOI-UHFFFAOYSA-N
분자식
C26H27N3O5S
평균 분자량
493.6 g/mol
단동위원소 질량
493.16714214

개요

Dasabuvir is a member of the class of pyrimidone, which is (as the monohydrate of its sodium salt) in combination with ombitasvir, paritaprevir and ritonavir (under the trade name Viekira Pak) for treatment of chronic hepatitis C virus genotype 1 infection as well as cirrhosis of the liver. It has a role as an antiviral drug and a nonnucleoside hepatitis C virus polymerase inhibitor. It is a member of naphthalenes, a sulfonamide, an aromatic ether and a pyrimidone. It is functionally related to a uracil.

이름 및 식별자

우선 이름
Dasabuvir
IUPAC
N-[6-[3-tert-butyl-5-(2,4-dioxopyrimidin-1-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamide
영어명
ABT-333
분자식
C26H27N3O5S
분자량
493.57

이름 및 동의어

Dasabuvir1132935-63-7ABT-333ABT333exvieraDE54EQW8T1N-(6-(3-tert-Butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamideABT 333CHEBI:85182DTXSID301025953N-[6-[3-tert-butyl-5-(2,4-dioxopyrimidin-1-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamideMethanesulfonamide, N-(6-(5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-(1,1-dimethylethyl)-2-methoxyphenyl)-2-naphthalenyl)-
이름 더 보기
CS-2000ABT-333/DasabuvirDasabuvir (ABT-333)Dasabuvir-13C 15N2 D3Dasabuvir, 10 mM in DMSON-{6-[3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]-2-naphthyl}methanesulfonamideN-{6-[5-(2,4-Dioxo-3,4-dihydro-1(2H)-pyrimidinyl)-2-methoxy-3-(2-methyl-2-propanyl)phenyl]-2-naphthyl}methanesulfonamide
N-{6-[3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl}methanesulfonamidedasabuvirumN-(6-(3-tert-butyl-5-(2,4-dioxopyrimidin-1-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamideRefChem:585200J05AP09DTXCID901510205805-439-9N-(6-(3-(tert-butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide

물성

구조 계산 물성

XLogP
4.3
극성 표면적
113 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
6
회전 가능 결합 수
6
무거운 원자 수
35
형식 전하
0
복잡도
938

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
Human DrugsBreast Feeding; Lactation; Milk, Human; Antiviral Agents

물리화학적 성질

녹는점
192 oC · >192oC (dec.)
밀도
1.317 · 1.317±0.06 g/cm3(Predicted)
저장 조건
-20 °C · Hygroscopic, -20°C Freezer, Under inert atmosphere
용해도
클로로포름(약간 용해됨, 가열), DMSO(약간 용해됨), 메탄올(약간 용해됨, 가열)
물리적 상태
고체
산도 계수 (pKa)
8.52 · 8.52±0.30(Predicted)
색상
옅은 갈색에서 밝은 갈색까지
InChI
InChI=1S/C26H27N3O5S/c1-26(2,3)22-15-20(29-11-10-23(30)27-25(29)31)14-21(24(22)34-4)18-7-6-17-13-19(28-35(5,32)33)9-8-16(17)12-18/h6-15,28H,1-5H3,(H,27,30,31)
InChIKey
NBRBXGKOEOGLOI-UHFFFAOYSA-N
SMILES
CS(NC1=CC=C2C(=C1)C=CC(C1=CC(N3C(=O)NC(=O)C=C3)=CC(C(C)(C)C)=C1OC)=C2)(=O)=O

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 3건

H413 (100%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]

P273, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory.

유해성 정보

Regulatory InformationREACH registered substance: N-{6-[3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl}methanesulfonamide (EC: 805-439-9)
Hazard Classes and CategoriesAquatic Chronic 4 (100%)

독성 정보

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

안전 데이터

wgk
WGK 3
Hazard Classifications
Aquatic Chronic 4
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

ATC Code · 2건

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

Protein BindingDasabuvir is greater than 99.5% bound to human plasma proteins.
PharmacodynamicsDasabuvir is classified as a direct-acting antiviral (DAA) and prevents viral replication in HCV genotype 1.
Mechanism of Action · 1건

Dasabuvir is a non-nucleoside inhibitor of the HCV RNA-dependent RNA polymerase encoded by the NS5B gene, which is essential for replication of the viral genome. Based on drug resistance mapping studies of HCV genotypes 1a and 1b, dasabuvir targets the palm domain of the NS5B polymerase, and is therefore referred to as a non-nucleoside NS5B-palm polymerase inhibitor. The EC50 values of dasabuvir against genotype 1a-H77 and 1b-Con1 strains in HCV replicon cell culture assays were 7.7 nM and 1.8 nM, respectively. By binding to NS5b outside of the active site of the enzyme, dasabuvir induces a conformational change thereby preventing further elongation of the nascent viral genome. A limitation of binding outside of the active site is that these binding sites are poorly preserved across the viral genotypes. This results in a limited potential for cross-genotypic activity and increased potential for development of resistance. Dasabuvir is therefore limited to treating genotypes 1a and 1b, and must be used in combination with other antiviral products.

Biological Half-LifeThe half-life of elimination of dasabuvir is 5.5 to 6 hours.
Metabolism/MetabolitesDasabuvir is predominantly metabolized by CYP2C8, and to a lesser extent by CYP3A.
FDA Pharmacological Classification · 6건

DE54EQW8T1

DASABUVIR

Established Pharmacologic Class [EPC] - Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor

Mechanisms of Action [MoA] - RNA Replicase Inhibitors

Mechanisms of Action [MoA] - UGT1A1 Inhibitors

관련 반응

38건
반응 기록 만들기
HRID 58403 반응식
HRID 58403생성물로
HRID 58404 반응식
HRID 58404생성물로
HRID 58405 반응식
HRID 58405생성물로
HRID 58406 반응식
HRID 58406생성물로
HRID 58407 반응식
HRID 58407생성물로
HRID 58408 반응식
HRID 58408생성물로
HRID 58409 반응식
HRID 58409생성물로
HRID 58410 반응식
HRID 58410생성물로
이전1 / 5 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

데이터베이스 식별자

CAS
1132935-63-7
PubChem CID
56640146
DTXSID
DTXSID301025953
ChEMBL
CHEMBL3137312
ChEBI
CHEBI:85182
UNII
DE54EQW8T1
EC Number
805-439-9
Nikkaji
J3.299.348F

Mechanisms of Action [MoA] - Breast Cancer Resistance Protein Inhibitors

Absorption, Distribution and Excretion · 4건

Dasabuvir reaches peak plasma concentration 4 hours after administration. The absolute bioavailability of Dasabuvir is 70%.

Dasabuvir is mainly excreted in the feces (94.4%) with very little excreted in the urine (2%). 26.2% and 0.03% of the drug excreted in the feces and urine respectively was present as the parent compound suggesting metabolism as the major elimination pathway.

Dasabuvir has a volume of distribution at steady state of 149 liters.

Clearance of Dasabuvir has not been determined.

응용 분야

용도Dasabuvir is an antiviral drug used in the treatment of chronic hepatitis C virus (HCV) infection.

상·하류 제품 정보

상류 원료

1-(3-tert-Butyl-5-iodo-4-Methoxyphenyl)pyriMidin-2,4(1H,3H)-dioneN-(6-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)-naphthalen-2-yl)MethanesulfonaMide탄산나트륨(경회)테트라 키스 (트리 페닐 포스 핀) 팔라듐 (0)1.4-다이옥세인물
추가 설명 · 1건

정의ChEBI: A member of the class of pyrimidone, which is (as the monohydrate of its sodium salt) in combination with ombitasvir, paritaprevir and ritonavir (under the trade name Viekira Pak) for treatment of chronic hepatitis C virus genotype 1 infection as well as c rrhosis of the liver.